Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Work In Process (2024 - 2025)

Historic Work In Process for CorMedix (CRMD) over the last 4 years, with Q3 2025 value amounting to $9.1 million.

  • CorMedix's Work In Process rose 7861.42% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year increase of 7861.42%. This contributed to the annual value of $3.5 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, CorMedix's Work In Process is $9.1 million, which was up 7861.42% from $5.2 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Work In Process ranged from a high of $9.1 million in Q3 2025 and a low of $471415.0 during Q1 2024